OrbiMed

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.

They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Their team of over 100 distinguished scientific, medical, investment, and other professionals manages over $17 billion across public and private company investments worldwide.

OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty.

OrbiMed manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. We invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide.

OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders. We invest globally, including across North America, Asia, and Europe.